The DOI matches its Crossref record; 304 of the 304 references it cites were found in a registry or an index.
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Open accessAbstract
Targeted covalent inhibitors (TCIs) are designed to bind poorly conserved amino acids by means of reactive groups, the so-called warheads. Currently, targeting noncatalytic cysteine residues with acrylamides and other α,β-unsaturated carbonyl compounds is the predominant strategy in TCI development. The recent ascent of covalent drugs has stimulated considerable efforts to characterize alternative warheads for the covalent-reversible and irreversible engagement of noncatalytic cysteine residues as well as other amino acids. This Perspective article provides an overview of warheads-beyond α,β-unsaturated amides-recently used in the design of targeted covalent ligands. Promising reactive groups that have not yet demonstrated their utility in TCI development are also highlighted. Special emphasis is placed on the discussion of reactivity and of case studies illustrating applications in medicinal chemistry and chemical biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–304 of 304
Napolitano, L., Scalise, M., Koyioni, M., Koutentis, P. A., Catto, M., Eberini, I., Parravicini, C., Palazzolo, L., Pisani, L., Galluccio, M., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.07.006 · Cited by 86
Selective Irreversible Chemical Tagging of Cysteine with 3-Arylpropiolonitriles
Koniev, O., Leriche, G., Nothisen, M., Rémy, J.-S., Strub, J., Schaeffer‐Reiss, C., DORSSELAER, A. V., Baati, R., & Wagner, A. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400469d · Cited by 85
Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery
Hallenbeck, K. K., Turner, D., Renslo, A. R., & Arkin, M. R. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160719163839 · Cited by 82
Tsukiji, S., & Hamachi, I. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.07.012 · Cited by 80
Zhao, S., Dai, J., Hu, M., Liu, C., Meng, R., Liu, X., Wang, C., & Luo, T. (2016) · Chemical Communications · doi:10.1039/c5cc10445a · Cited by 79
Shearer, B. G., Wiethe, R. W., Ashe, A., Billin, A. N., Way, J. M., Stanley, T. B., Wagner, C. D., Xu, R. X., Leesnitzer, L. M., Merrihew, R. V., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900464j · Cited by 78
An Irreversible Inhibitor of HSP72 that Unexpectedly Targets Lysine‐56
Pettinger, J., Bihan, Y. L., Widya, M., van Montfort, R. L. M., Jones, K., & Cheeseman, M. D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611907 · Cited by 78
Swatek, K. N., Aumayr, M., Pruneda, J. N., Visser, L. J., Berryman, S., Kueck, A. F., Geurink, P. P., Ovaa, H., van Kuppeveld, F. J. M., Tuthill, T. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710617115 · Cited by 78
A Specific and Covalent JNK‐1 Ligand Selected from an Encoded Self‐Assembling Chemical Library
Zimmermann, G., Rieder, U., Bajic, D., Vanetti, S., Chaikuad, A., Knapp, S., Scheuermann, J., Mattarella, M., & Neri, D. (2017) · Chemistry – A European Journal · doi:10.1002/chem.201701644 · Cited by 77
Zapf, C. W., Gerstenberger, B. S., Li, X., Limburg, D. C., Anderson, D. R., Caspers, N. L., Han, S., AULABAUGH, A. E., Kurumbail, R. G., Shakya, S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301190s · Cited by 76
Bandyopadhyay, A., & Gao, J. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502077 · Cited by 76
Cysteine-reactive probes and their use in chemical proteomics
Hoch, D. G., Abegg, D., & Adibekian, A. (2018) · Chemical Communications · doi:10.1039/c8cc01485j · Cited by 76
Zambaldo, C., Daguer, J.-P., Saarbach, J., Barluenga, S., & Winssinger, N. (2016) · MedChemComm · doi:10.1039/c6md00242k · Cited by 75
Dahal, U. P., Gilbert, A. M., Obach, R. S., Flanagan, M. E., Chen, J. M., García-Irizarry, C. N., Starr, J. T., Schuff, B. P., Uccello, D. P., & Young, J. A. (2016) · MedChemComm · doi:10.1039/c6md00017g · Cited by 75
Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8
Porter, N. J., & Christianson, D. W. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00330 · Cited by 74
Karala, A., Lappi, A., & Ruddock, L. W. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.12.014 · Cited by 73
Acalabrutinib: First Global Approval
Markham, A., & Dhillon, S. (2017) · Drugs · doi:10.1007/s40265-017-0852-8 · Cited by 73
Yamaguchi, S., Aldini, G., Ito, S., Morishita, N., Shibata, T., Vistoli, G., Carini, M., & Uchida, K. (2009) · Journal of the American Chemical Society · doi:10.1021/ja908878n · Cited by 67
Friedman, M., & Wall, J. S. (1966) · The Journal of Organic Chemistry · doi:10.1021/jo01347a036 · Cited by 66
Förster, M., Chaikuad, A., Dimitrov, T., Döring, E., Holstein, J., Berger, B., Gehringer, M., Ghoreschi, K., Müller, S., Knapp, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00571 · Cited by 66
Self-citationCan Relative Binding Free Energy Predict Selectivity of Reversible Covalent Inhibitors?
Chatterjee, P., Botello‐Smith, W. M., Zhang, H., Qian, L., Alsamarah, A., Kent, D., Lacroix, J. J., Baudry, M., & Luo, Y. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08938 · Cited by 65
Schiff Bases in Biological Systems
Ritter, E., Przybylski, P., Brzeziński, B., & Bartl, F. J. (2009) · Current Organic Chemistry · doi:10.2174/138527209787314805 · Cited by 64
Jakob, C. G., Upadhyay, A. K., Donner, P. L., Nicholl, E., Addo, S. N., Qiu, W., Ling, C., Gopalakrishnan, S. M., Torrent, M., Cepa, S. P., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00305 · Cited by 62
Eckstein, J. W., Foster, P., Finer-Moore, J. S., Wataya, Y., & Santi, D. V. (1994) · Biochemistry · doi:10.1021/bi00254a018 · Cited by 61
Ouertatani-Sakouhi, H., El-Turk, F., Fauvet, B., Roger, T., Roy, D. L., Karpinar, D. P., Leng, L., Bucala, R., Zweckstetter, M., Calandra, T., et al. (2009) · Biochemistry · doi:10.1021/bi900957e · Cited by 59
Covalent Molecular Probes for Class A G Protein-Coupled Receptors: Advances and Applications
Weichert, D., & Gmeiner, P. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00070 · Cited by 59
A tyrosine-reactive irreversible inhibitor for glutathione S -transferase Pi (GSTP1)
Crawford, L. A., & Weerapana, E. (2016) · Molecular BioSystems · doi:10.1039/c6mb00250a · Cited by 59
Kharenko, O. A., Patel, R. G., Brown, S. D., Calosing, C., White, A., Damodharan, L., Suto, R. K., Duffy, B. C., Kitchen, D. B., McLure, K. G., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00666 · Cited by 59
How Reactive are Druggable Cysteines in Protein Kinases?
Awoonor‐Williams, E., & Rowley, C. N. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00454 · Cited by 58
Transthiocarbamoylation of Proteins by Thiolated Isothiocyanates
Shibata, T., Kimura, Y., Mukai, A., Mori, H., Ito, S., Asaka, Y., Oe, S., TANAKA, H. L., Takahashi, T., & Uchida, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308049 · Cited by 55
Site‐Specific Labeling of Proteins with a Chemically Stable, High‐Affinity Tag for Protein Study
Yang, Y., Li, Q., Cao, C., Huang, F., & Su, X. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202495 · Cited by 53
Carmi, C., Cavazzoni, A., Vezzosi, S., Bordi, F., Vacondio, F., Silva, C., Rivara, S., Lodola, A., Alfieri, R. R., Monica, S. L., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901558p · Cited by 51
Miyahisa, I., Sameshima, T., & Hixon, M. S. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505800 · Cited by 51
From Covalent Glycosidase Inhibitors to Activity‐Based Glycosidase Probes
Willems, L. I., Jiang, J., Li, K., Witte, M. D., Kallemeijn, W. W., Beenakker, T. J. M., Schröder, S. P., Aerts, J. M. F. G., van der Marel, G. A., Codée, J. D. C., et al. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201404014 · Cited by 51
Chemoproteomics‐Enabled Discovery of a Potent and Selective Inhibitor of the DNA Repair Protein MGMT
Wang, C., Abegg, D., Hoch, D. G., & Adibekian, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201511301 · Cited by 51
Reactive Chemical Probes: Beyond the Kinase Cysteinome
Jones, L. H. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802693 · Cited by 51
Chemoselective Tyrosine Bioconjugation through Sulfate Click Reaction
Choi, E. J., Jung, D., Kim, J., Lee, Y., & Kim, B. M. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201802380 · Cited by 50
Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype
Lopus, M., Smiyun, G., Miller, H. P., Oroudjev, E., Wilson, L., & Jordan, M. A. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2863-z · Cited by 49
Targeted Covalent Enzyme Inhibitors
Noe, M. C., & Gilbert, A. M. (2012) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-396492-2.00027-8 · Cited by 49
Fairhurst, R. A., Knöpfel, T. F., Leblanc, C., Buschmann, N., Gaul, C., Blank, J., Galuba, I., Trappe, J., Zou, C., Voshol, J., et al. (2017) · MedChemComm · doi:10.1039/c7md00213k · Cited by 49
Allimuthu, D., & Adams, D. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00424 · Cited by 49
Knöpfel, T. F., Furet, P., Mah, R., Buschmann, N., Leblanc, C., Ripoche, S., Graus-Porta, D., Wartmann, M., Galuba, I., & Fairhurst, R. A. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00485 · Cited by 49
Evans, M. J., Morris, G. M., Wu, J., Olson, A. J., Sorensen, E. J., & Cravatt, B. F. (2007) · Molecular BioSystems · doi:10.1039/b705113a · Cited by 48
Klüter, S., Simard, J. R., Rode, H. B., Grütter, C., Pawar, V. T., Raaijmakers, H. C. A., Barf, T. A., Rabiller, M., van Otterlo, W. A. L., & Rauh, D. (2010) · ChemBioChem · doi:10.1002/cbic.201000352 · Cited by 48
New drug design with covalent modifiers
Adeniyi, A. A., Ramesh, M., & Soliman, M. E. S. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1115478 · Cited by 48
Lively, M. O., & Powers, J. C. (1978) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(78)90211-5 · Cited by 46
Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase
Ban, H. S., Usui, T., Nabeyama, W., Morita, H., Fukuzawa, K., & Nakamura, H. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b909504g · Cited by 45
Metabolically Labile Fumarate Esters Impart Kinetic Selectivity to Irreversible Inhibitors
Zaro, B. W., Whitby, L. R., Lum, K. M., & Cravatt, B. F. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10589 · Cited by 45
Arnold, L. A., Kosinski, A. M., Estébanez‐Perpiñá, E., & Guy, R. K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070556y · Cited by 44
Baker, B. R. (1969) · Accounts of Chemical Research · doi:10.1021/ar50017a001 · Cited by 44
Qian, Y., Schürmann, M., Janning, P., Hedberg, C., & Waldmann, H. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602666 · Cited by 43
Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting
Förster, M., Gehringer, M., & Laufer, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.07.079 · Cited by 43
Self-citationNorbornene probes for the study of cysteine oxidation
Alcock, L. J., Farrell, K. D., Akol, M. T., Jones, G. H., Tierney, M. M., Kramer, H., Pukala, T. L., Bernardes, G. J. L., Perkins, M. V., & Chalker, J. M. (2017) · Tetrahedron · doi:10.1016/j.tet.2017.11.011 · Cited by 43
Targeting Protein Kinases with Selective and Semipromiscuous Covalent Inhibitors
Miller, R. M., & Taunton, J. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-397918-6.00004-5 · Cited by 42
The Nitro Group as a Masked Electrophile in Covalent Enzyme Inhibition
Ray, S., Kreitler, D. F., Gulick, A. M., & Murkin, A. S. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00225 · Cited by 42
A Simple Method for Enhancing the Bioorthogonality of Cyclooctyne Reagent
Tian, H., Sakmar, T., & Huber, T. (2016) · Chemical Communications · doi:10.1039/c6cc01321j · Cited by 41
Waterson, A. G., Petrov, K. G., Hornberger, K. R., Hubbard, R. D., Sammond, D. M., Smith, S. C., Dickson, H. D., Caferro, T. R., Hinkle, K. W., Stevens, K. L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.080 · Cited by 40
Schwans, J. P., Sunden, F., Gonzalez, A. M., Tsai, Y., & Herschlag, D. (2013) · Biochemistry · doi:10.1021/bi401083b · Cited by 40
The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase
Cross, J. V., Foss, F. W., Rady, J. M., Macdonald, T. L., & Templeton, D. J. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-183 · Cited by 40
Moynihan, M. M., & Murkin, A. S. (2013) · Biochemistry · doi:10.1021/bi401432t · Cited by 40
Harlow, K. W., & Switzer, R. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39388-3 · Cited by 39
Crow, J. A., Bittles, V., Borazjani, A., Potter, P. M., & Ross, M. K. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.017 · Cited by 38
Morgen, M., Jöst, C., Malz, M., Janowski, R., Niessing, D., Klein, C. D. P., Gunkel, N., & Miller, A. K. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00755 · Cited by 38
Garzón, B., Oeste, C. L., Díez-Dacal, B., & Pérez‐Sala, D. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.03.028 · Cited by 35
Characterization of Covalent-Reversible EGFR Inhibitors
Smith, S. P., Keul, M., Engel, J., Basu, D., Eppmann, S., & Rauh, D. (2017) · ACS Omega · doi:10.1021/acsomega.7b00157 · Cited by 35
Hwang, J. Y., Huang, W., Arnold, L. A., Huang, R., Attia, R. R., Connelly, M., Wichterman, J., Zhu, F., Augustinaite, I., Austin, C. P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200436 · Cited by 34
Modeling the Clinical Phenotype of BTK Inhibition in the Mature Murine Immune System
Benson, M. J., Rodriguez, V., von Schack, D., Keegan, S., Cook, T. A., Edmonds, J., Benoit, S., Seth, N. P., Du, S., Messing, D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302570 · Cited by 33
Vinyl sulfone building blocks in covalently reversible reactions with thiols
Schneider, T., Rieger, M., Ansorg, K., Sobolev, A. N., Schirmeister, T., Engels, B., & Grabowsky, S. (2015) · New Journal of Chemistry · doi:10.1039/c5nj00368g · Cited by 33
The preparation of the first α-vinylidene-β-lactams
Buynak, J. D., Mathew, J., Rao, M. N., Haley, E., George, C., & Siriwardane, U. (1987) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39870000735 · Cited by 33
Rational design of reversible and irreversible cysteine sulfenic acid-targeted linear C-nucleophiles
Gupta, V., & Carroll, K. S. (2016) · Chemical Communications · doi:10.1039/c6cc00228e · Cited by 33
Assessment of reagents for selenocysteine conjugation and the stability of selenocysteine adducts
Pedzisa, L., Li, X., Rader, C. M., & Roush, W. R. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob00775a · Cited by 33
A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors
Chen, K. X., Lesburg, C. A., Vibulbhan, B., Yang, W., Chan, T., Venkatraman, S., Velázquez, F., Zeng, Q., Bennett, F., Anilkumar, G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201322r · Cited by 32
Discovery of a Small-Molecule Modulator of Glycosaminoglycan Sulfation
Cheung, S. T., Miller, M. S., Pacoma, R., Roland, J. T., Liu, J., Schumacher, A. M., & Hsieh‐Wilson, L. C. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00885 · Cited by 32
Chen, D., Guo, D., Yan, Z., & Zhao, Y. (2017) · MedChemComm · doi:10.1039/c7md00571g · Cited by 32
Yoshizawa, M., Itoh, T., Hori, T., Kato, A., Anami, Y., Yoshimoto, N., & Yamamoto, K. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00774 · Cited by 32
Visperas, P. R., Winger, J. A., Horton, T. M., Shah, N. H., Aum, D. J., Tao, A., Barros, T. F., Yan, Q., Wilson, C. G. M., Arkin, M. R., et al. (2014) · Biochemical Journal · doi:10.1042/bj20140793 · Cited by 31
Kumari, V., Dyba, M., Holland, R. J., Liang, Y., Singh, S. V., & Ji, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163821 · Cited by 30
A covalent antagonist for the human adenosine A2A receptor
Yang, X., Dong, G., Michiels, T. J. M., Lenselink, E. B., Heitman, L. H., Louvel, J., & IJzerman, A. P. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9549-9 · Cited by 30
Hou, W., Ren, Y., Zhang, Z., Sun, H., Ma, Y., & Yan, B. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.02.022 · Cited by 28
Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide
Li, T., Maltais, R., Poirier, D., & Lin, S. (2018) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.8b02225 · Cited by 27
Arkona, C., & Rademann, J. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201303544 · Cited by 26
Redox-based probes as tools to monitor oxidized protein tyrosine phosphatases in living cells
García, F., & Carroll, K. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.040 · Cited by 25
Synthesis and hetero-Michael addition reactions of 2-alkynyl oxazoles and oxazolines
Wipf, P., & Graham, T. H. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b413604g · Cited by 24
Schapira, A. H. V., Bate, G., & Kirkpatrick, P. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1803 · Cited by 24
Covalent Probe Finds Carboxylic Acid
Jones, A., Zhang, X., & Lei, X. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.05.003 · Cited by 23
Tjin, C. C., Otley, K. D., Baguley, T. D., Kurup, P. K., Xu, J., Nairn, A. C., Lombroso, P. J., & Ellman, J. A. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00486 · Cited by 22
Adams, B. T., Niccoli, S., Chowdhury, M. A., Esarik, A. N. K., Lees, S. J., Rempel, B. P., & Phenix, C. P. (2015) · Chemical Communications · doi:10.1039/c5cc03828f · Cited by 20
Gehringer, M., Förster, M., & Laufer, S. (2014) · ACS Combinatorial Science · doi:10.1021/co500122h · Cited by 20
Self-citation3-Cyano-3-aza-β-amino Acid Derivatives as Inhibitors of Human Cysteine Cathepsins
Schmitz, J., Beckmann, A., Dudić, A., Li, T., Sellier, R., Bartz, U., & Gütschow, M. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500238q · Cited by 19
Visperas, P. R., Wilson, C. G., Winger, J. A., Yan, Q., Lin, K., Arkin, M. R., Weiss, A., & Kuriyan, J. (2017) · SLAS Discovery · doi:10.1177/1087057116681407 · Cited by 19
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates
Lewis, S. M., Li, Y., Catalano, M. J., Laciak, A. R., Singh, H., Seiner, D. R., Reilly, T. J., Tanner, J. J., & Gates, K. S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.08.065 · Cited by 18
Moss, D. E., Fariello, R. G., Sahlmann, J., Sumaya, I. C., Pericle, F., & Braglia, E. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12018 · Cited by 18
Recent Advances in Irreversible Kinase Inhibitors
Gilbert, A. M. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.14.24 · Cited by 18
Pearson, R. J., Blake, D., Mezna, M., Fischer, P. M., Westwood, N. J., & McInnes, C. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.06.001 · Cited by 17
Pitscheider, M., Mäusbacher, N., & Sieber, S. A. (2012) · Chemical Science · doi:10.1039/c2sc20290e · Cited by 16
Selective Covalent Protein Modification by 4‐Halopyridines through Catalysis
Schardon, C. L., Tuley, A., Er, J. A. V., Swartzel, J. C., & Fast, W. L. (2017) · ChemBioChem · doi:10.1002/cbic.201700104 · Cited by 15
Potent haloperidol derivatives covalently binding to the dopamine D2 receptor
Schwalbe, T., Kaindl, J. M., Hübner, H., & Gmeiner, P. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.034 · Cited by 15
Roedig, A., & Ritschel, W. (1983) · Chemische Berichte · doi:10.1002/cber.19831160434 · Cited by 14
Discovery of an irreversible HCV NS5B polymerase inhibitor
Zeng, Q., Nair, A. G., Rosenblum, S. B., Huang, H., Lesburg, C. A., Jiang, Y., Selyutin, O., Chan, T., Bennett, F., Chen, K. X., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.060 · Cited by 12
Development of 5N-Bicalutamide, a High-Affinity Reversible Covalent Antiandrogen
Cortez, F. D. J., Nguyen, P., Truillet, C., Tian, B., Kuchenbecker, K. M., Evans, M. J., Webb, P., Jacobson, M. P., Fletterick, R. J., & England, P. M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00702 · Cited by 12
Sato, K., Kunitomo, Y., Kasai, Y., Utsumi, S., Suetake, I., Tajima, S., Ichikawa, S., & Matsuda, A. (2018) · ChemBioChem · doi:10.1002/cbic.201700688 · Cited by 12
Identification of Noncatalytic Lysine Residues from Allosteric Circuits via Covalent Probes
Bongard, J., Lorenz, M., Vetter, I. R., Stege, P., Porfetye, A. T., Schmitz, A. L., Kaschani, F., Wolf, A., Koch, U., Nußbaumer, P., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00101 · Cited by 11
Kasai, Y., Sato, K., Utsumi, S., & Ichikawa, S. (2018) · ChemBioChem · doi:10.1002/cbic.201800244 · Cited by 8
Tuning kinase inhibitor residence time
Cully, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4673 · Cited by 7
Cited by
RAS-targeted therapies: is the undruggable drugged?
Moore, A. R., Rosenberg, S. C., McCormick, F., & Malek, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0068-6 · Cited by 1,103
Spirocyclic Scaffolds in Medicinal Chemistry
Hiesinger, K., Dar’in, D., Proschak, E., & Krasavin, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01473 · Cited by 618
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Nalawansha, D. A., & Crews, C. M. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.07.020 · Cited by 490
Ertl, P., Altmann, E., & McKenna, J. M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00754 · Cited by 429
Covalent inhibitors: a rational approach to drug discovery
Sutanto, F., Konstantinidou, M., & Dömling, A. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00154f · Cited by 389
Metadata
- Authors
- Gehringer, M., & Laufer, S. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-12-19
- Volume
- 62
- Issue
- 12
- Pages
- 5673-5724
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2904506792
- Cited by
- 714
- References
- 304
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.